Cardurion Pharmaceuticals
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
78 Blanchard Rd Ste 200, Burlington, Mas...Phone Number
(617) 863-8088Website
www.cardurion.comRevenue
$13.7 MillionIndustry
About Cardurion Pharmaceuticals
Cardurion Pharmaceuticals Org Chart
Is Cardurion Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cardurion Pharmaceuticals had a recent Job posting/layoffs
Check if Cardurion Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Cardurion Pharmaceuticals
Earning: See what the market has to say on Cardurion Pharmaceuticals recently announced quarterly report
Cardurion Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Cardurion Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Cardurion Pharmaceuticals has new funding data
Check out if Cardurion Pharmaceuticals is spiking on competitors!
Recommended Actions
Find VP level buyers at Cardurion Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Cardurion Pharmaceuticals
Compare insights from companies similar to Cardurion Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cardurion Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cardurion Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cardurion Pharmaceuticals.
Cardurion Pharmaceuticals financials insights
Gather financial insights about Cardurion Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$300M
Cardurion Pharmaceuticals Tech Stack
A closer look at the technologies used by Cardurion Pharmaceuticals
Most Recent Scoops
Cardurion Pharmaceuticals News & Media
Cardurion Pharmaceuticals Appoints Karen Lewis as Chief People Officer
BURLINGTON, Mass.--(BUSINESS WIRE)--Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company discovering and developing new therapeutic approaches for the treatment of cardiovascular diseases, today announced that Karen Lewis has joined the company as Chief People Officer. She joins Cardurion with more than 25 years of experience in human resources helping to build organizations and develop programs that support companies at various stages of growth. She most recentCardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer
BURLINGTON, Mass.--(BUSINESS WIRE)--Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company discovering and developing new therapeutic approaches for the treatment of cardiovascular diseases, today announced that Charlotte (Charlie) Newman has joined the company as Chief Business Officer. A biopharmaceutical industry executive with over 25 years of industry experience, Ms. Newman most recently led corporate, portfolio and program strategy and business development aCardurion Pharmaceuticals Selected as an Endpoints 11 Most Promising Biotech Company
BURLINGTON, Mass.--(BUSINESS WIRE)--Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced that it has been named as one of the Endpoints 11 most promising private biotechnology companies of 2024. Cardurion has been chosen by the Endpoints News editorial team because of the company’s strengths in science, leadership, investors and strategy to develop the next gene
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Cardurion Pharmaceuticals
Cardurion Pharmaceuticals is a biotechnology company focused on the discovery and development of next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases. Cardurion Pharmaceuticals was founded in 2017 and based in Boston, Massachusetts.... Read More

